ResMed (NYSE: RMD) announced revenue of US$411.6 million for the three months to the end of September, a rise of 8 per cent compared to the corresponding period last year (15 per cent on a constant currently basis).
ResMed is a global leader in the development and commercialisation of devices and treatments for sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases.
“Our global team was able to drive strong double-digit constant currency growth in the first quarter of fiscal year 2016. This result was led by 39 percent flow generator and 9 percent mask growth in the Americas,” said Mick Farrell, ResMed’s CEO. “We are investing for ongoing expansion and leadership in our high-growth regions. In October, we completed the acquisition of Curative Medical, making our combined ResMed and Curative business the market leader in sleep-disordered breathing and respiratory care in China.”
Farrell continued, “It has been a year since we launched our Air Solutions Platform. We have made incredible progress, with over one million patients with cloud-connected devices on bedside tables, providing actionable data every day for patients, customers, providers and payors. Our leading informatics capabilities enable our global team to enhance and deliver the most innovative products and solutions that improve patient outcomes, create efficiencies for our customers, help providers better manage chronic disease and lower healthcare costs. We have established ourselves as leaders in the field of connected care and digital health.”
In the three months to September, revenue from the company's Americas operation was up 23 per cent to [US[$254.2 million.
"Revenue in combined EMEA and APAC was [US]$157.5 million, a 9 percent decrease compared with the quarter ended September 30, 2014 (a 5 percent increase on a constant currency basis)," it said.
"Income from operations for the quarter was [US]$98.0 million, a 4 percent increase compared with the quarter ended September 30, 2014. Non-GAAP income from operations for the quarter was $100.3 million, a 4 percent increase compared with the quarter ended September 30, 2014," added the company.